The Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations, Outcomes (REACH-OUT) study: real-world clinical practice in schizophrenia

by Kruti Joshi, Lian Mao, David M. Biondi, Robert Millet
Published 2018-01-01

Comparison and predictors of treatment adherence and remission among patients with schizophrenia treated with paliperidone palmitate or atypical oral antipsychotics in community be...

by Jeffrey P. Anderson, Zeynep Icten, Veronica Alas, Carmela Benson, Kruti Joshi
Published 2017-10-01

Adherence, healthcare resource utilization and Medicaid spending associated with once-monthly paliperidone palmitate versus oral atypical antipsychotic treatment among adults recen...

by Dominic Pilon, Erik Muser, Patrick Lefebvre, Rhiannon Kamstra, Bruno Emond, Kruti Joshi
Published 2017-06-01

Correction: Burden of treatment-resistant depression in Medicare: A retrospective claims database analysis.

by Dominic Pilon, Kruti Joshi, John J Sheehan, Miriam L Zichlin, Peter Zuckerman, Patrick Lefebvre, Paul E Greenberg
Published 2021-01-01

Burden of treatment-resistant depression in Medicare: A retrospective claims database analysis.

by Dominic Pilon, Kruti Joshi, John J Sheehan, Miriam L Zichlin, Peter Zuckerman, Patrick Lefebvre, Paul E Greenberg
Published 2019-01-01

How well do clinical and demographic characteristics predict Patient Health Questionnaire‐9 scores among patients with treatment‐resistant major depressive disorder in a real‐world...

by Jennifer Voelker, Kruti Joshi, Ella Daly, Eros Papademetriou, David Rotter, John J. Sheehan, Harsh Kuvadia, Xing Liu, Anandaroop Dasgupta, Ravi Potluri
Published 2021-02-01